22.03.2017 17:41:00

Cantel Medical to Present at the 16th Annual Needham & Company Healthcare Conference

LITTLE FALLS, N.J., March 22, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 16th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 5, 2017 at 3:00 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.

A live audio webcast will be available via the investor relations page of the Cantel website at www.cantelmedical.com. A replay of the presentation will be archived on the Cantel website for those unable to listen live.

About Cantel Medical Corp.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. 

For further information, visit the Cantel website at www.cantelmedical.com.

 

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-to-present-at-the-16th-annual-needham--company-healthcare-conference-300427866.html

SOURCE Cantel Medical Corp.

Nachrichten zu Cantel Medical Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cantel Medical Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!